Sanofi unveiled a plan to build a $1 billion manufacturing site in Beijing while completing construction at a plant in ...

GSK plc GSK announced that it has revised its collaboration deal with Chongqing Zhifei Biological Products (Zhifei), China's largest vaccine maker, to co-market its shingles vaccine Shingrix in ...

GSK (GSK) announced that it has entered into an agreement with Chongqing Zhifei Biological Products to revise the terms on which Zhifei will commercialise GSK’s shingles vaccine, Shingrix, in ...

GSK said on Thursday that Zhifei will commercialise its shingles vaccine, Shingrix, in mainland China, with the revised agreement extending the original three-year period during which the latter ...

(Alliance News) - GSK PLC on Thursday said it has expanded its shingles vaccine collaboration with Chongqing Zhifei Biological Products Ltd in China, including an extended term length. The ...

to revise the terms on which Zhifei will commercialize GSK's shingles vaccine, Shingrix, in mainland China. This agreement serves as an amendment to the previously announced contract from October ...

to revize the terms on which Zhifei will commercialize GSK’s shingles vaccine, Shingrix,in mainland China. The revised agreement extends the original three-year period (2024-2026) during which Zhifei ...

The European Commission (EC) has granted approval for a single-vial, fully liquid presentation of GSK's Menveo vaccine (MenACWY), designed to protect against invasive meningococcal disease (IMD ...

SINGAPORE – A French pharmaceutical giant has opened a new $800 million manufacturing facility in Tuas Biomedical Park ... in Singapore – will produce vaccines and other biopharmaceutical ...